CAN
KRBP

Cetera Advisor Networks’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Cetera Advisor Networks’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-350
Closed -$3K – 2617
2022
Q3 		$3K Buy
+350
New +$4.06K ﹤0.01% 2079

Other funds holding KRBP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cetera Advisor Networks's KRBP Position: Q4 2022 in Review

Cetera Advisor Networks sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q4 2022, closing a stake of 350 shares — an estimated $3K sold.

Cetera Advisor Networks first reported a position in KRBP in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 12 funds tracked by Wall St. Rank hold KRBP as of Q4 2022.

  • Cetera Advisor Networks reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cetera Advisor Networks sold 350 Kiromic BioPharma, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Cetera Advisor Networks first reported a position in Kiromic BioPharma, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Cetera Advisor Networks's Kiromic BioPharma, Inc. Common Stock position peaked at $3K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q4 2022.

Based on Cetera Advisor Networks's 13F filing for Q4 2022, filed 14 Feb 2023.